Skip to main content
SpringerLink
Log in
Book cover

Core Concepts in Parenchymal Kidney Disease pp 229–240Cite as

Cytomegalovirus, BK, and Other Viral Infections of the Kidney

  • Chapter
  • First Online:

Abstract

Viruses are relatively uncommon but important cause of renal infection. Viral pathogens such as cytomegalovirus (CMV), polyomaviruses (JC or BK virus), and adenoviruses are able to replicate in the kidney, and symptomatic infection with these agents can be associated with significant morbidity and mortality in immunocompromised hosts such as renal allograft recipients. Of these, CMV is a particular problem in kidney transplant recipients and can result in temporary or irreversible renal dysfunction. CMV disease in immunocompromised patients is usually due to reactivation of the latent virus. Renal manifestation of CMV infection may include tubulointerstitial nephritis and glomerulopathy. Classic histologic findings in CMV nephritis include evidence of interstitial nephritis and characteristic “owl’s eyes” representing intracellular inclusions. Antiviral therapy is usually reserved for immunocompromised hosts.

BK polyomaviruses also have tropism for urinary epithelium. Symptomatic renal disease with polyomaviruses has only been described in immunocompromised patients, and clinical manifestations in this patient population may include tubulointerstitial nephritis, ureteral stenosis, and hemorrhagic cystitis. Similar to CMV, renal disease with BK virus in kidney transplant recipients is primarily due to reactivation of the latent virus. BK nephritis should be suspected in patients with allograft dysfunction who are found to have “decoy cells” in urinalysis, and the diagnosis is usually confirmed based on histopathologic findings and BK virus PCR (polymerase chain reaction). Reduction in immunosuppression is the cornerstone of therapy in BK virus nephritis.

Renal infection with adenovirus is rare but has been associated with necrotizing tubulointerstitial nephritis in kidney transplant recipients and hemorrhagic cystitis in bone marrow transplant patients. Other viruses that may cause renal injury include Coxsackie and hantavirus groups.

This is a preview of subscription content, log in via an institution.

Chapter
USD   29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD   89.00
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD   119.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info
Hardcover Book
USD   169.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Learn about institutional subscriptions

References

  1. Mandell GL, editor. Mandell: Mandell, Douglas, and Bennett’s principles and practice of infectious diseases. 7th ed. Philadelphia, PA: Churchill Livingstone Elsevier; 2009.

    Google Scholar 

  2. Ustinov JA, Loginov RJ, Mattila PM, et al. Cytomegalovirus infection of human kidney cells in vitro. Kidney Int. 1991; 40(5):954–60.

    Article  PubMed  CAS  Google Scholar 

  3. Heieren MH, Kim YK, Balfour Jr HH. Human cytomegalovirus infection of kidney glomerular visceral epithelial and tubular epithelial cells in culture. Transplantation. 1988;46(3):426–32.

    PubMed  CAS  Google Scholar 

  4. Heieren MH, van der Woude FJ, Balfour Jr HH. Cytomegalovirus replicates efficiently in human kidney mesangial cells. Proc Natl Acad Sci USA. 1988;85(5):1642–6.

    Article  PubMed  CAS  Google Scholar 

  5. van Dorp WT, van Wieringen PA, Marselis-Jonges E, et al. Cytomegalovirus directly enhances MHC class I and intercellular adhesion molecule-1 expression on cultured proximal tubular epithelial cells. Transplantation. 1993;55(6):1367–71.

    Article  PubMed  Google Scholar 

  6. Osawa R, Singh N. Cytomegalovirus infection in critically ill patients: a systematic review. Crit Care. 2009;13(3):R68.

    Article  PubMed  Google Scholar 

  7. Platt JL, Sibley RK, Michael AF. Interstitial nephritis associated with cytomegalovirus infection. Kidney Int. 1985;28(3):550–2.

    Article  PubMed  CAS  Google Scholar 

  8. Kaminska A, Roszkowska-Blaim M, Weglarska J, et al. [Rare causes of interstitial nephritis in two children]. Wiad Lek. 2005;58 Suppl 1:93–7.

    PubMed  Google Scholar 

  9. Matsukura H, Itoh Y, Kanegane H, Arai M, Miyawaki T, Murakami G. Acute tubulointerstitial nephritis: possible association with cytomegalovirus infection. Pediatr Nephrol. 2006;21(3):442–3.

    Article  PubMed  Google Scholar 

  10. Chirumamilla SR, He C, Racusen LC, Scheimann AO, Cuffari C. Acute kidney injury in a girl with ulcerative colitis and cytomegalovirus-induced focal segmental glomerular sclerosis. World J Pediatr. 2013;9(1):84–6.

    Article  PubMed  Google Scholar 

  11. Trimarchi H, Jordan R, Iotti A, et al. Late-onset cytomegalovirus-associated interstitial nephritis in a kidney transplant. Nephron. 2002;92(2):490–4.

    Article  PubMed  Google Scholar 

  12. Ulrich W, Schlederer MP, Buxbaum P, et al. The histopathologic identification of CMV infected cells in biopsies of human renal allografts. An evaluation of 100 transplant biopsies by in situ hybridization. Pathol Res Pract. 1986;181(6):739–45.

    Article  PubMed  CAS  Google Scholar 

  13. Joshi K, Nada R, Radotra BD, Jha V, Sakhuja V. Pathological spectrum of cytomegalovirus infection of renal allograft recipients-an autopsy study from north India. Indian J Pathol Microbiol. 2004;47(3):327–32.

    PubMed  Google Scholar 

  14. Ozdemir BH, Sar A, Uyar P, Suren D, Demirhan B, Haberal M. Posttransplant tubulointerstitial nephritis: clinicopathological correlation. Transplant Proc. 2006;38(2):466–9.

    Article  PubMed  CAS  Google Scholar 

  15. Cameron J, Rigby RJ, van Deth AG, Petrie JJ. Severe tubulo-interstitial disease in a renal allograft due to cytomegalovirus infection. Clin Nephrol. 1982;18(6):321–5.

    PubMed  CAS  Google Scholar 

  16. Tiple A, Kamar N, Esposito L, et al. Unusual presentation of cytomegalovirus infection in patients after organ transplant. Exp Clin Transplant. 2009;7(1):45–9.

    PubMed  Google Scholar 

  17. Castro LA, Gokel JM, Thoenes G, et al. Renal changes in cytomegalovirus infection. Proc Eur Dial Transplant Assoc. 1983; 19:500–4.

    PubMed  CAS  Google Scholar 

  18. Herrera GA, Alexander RW, Cooley CF, et al. Cytomegalovirus glomerulopathy: a controversial lesion. Kidney Int. 1986; 29(3):725–33.

    Article  PubMed  CAS  Google Scholar 

  19. Battegay EJ, Mihatsch MJ, Mazzucchelli L, et al. Cytomegalovirus and kidney. Clin Nephrol. 1988;30(5):239–47.

    PubMed  CAS  Google Scholar 

  20. Birk PE, Chavers BM. Does cytomegalovirus cause glomerular injury in renal allograft recipients? J Am Soc Nephrol. 1997; 8(11):1801–8.

    PubMed  CAS  Google Scholar 

  21. Shorr RI, Longo WL, Oberley TD, Bozdech MJ, Walker DL. Cytomegalovirus-associated tubulointerstitial nephritis in an allogeneic bone marrow transplant recipient. Ann Intern Med. 1987;107(3):351–2.

    Article  PubMed  CAS  Google Scholar 

  22. Razonable RR. Antiviral drugs for viruses other than human immunodeficiency virus. Mayo Clin Proc. 2011;86(10):1009–26.

    Article  PubMed  CAS  Google Scholar 

  23. Gardner SD, Field AM, Coleman DV, Hulme B. New human papovavirus (B.K.) isolated from urine after renal transplantation. Lancet. 1971;1(7712):1253–7.

    Article  PubMed  CAS  Google Scholar 

  24. Randhawa PS, Finkelstein S, Scantlebury V, et al. Human polyoma virus-associated interstitial nephritis in the allograft kidney. Transplantation. 1999;67(1):103–9.

    Article  PubMed  CAS  Google Scholar 

  25. Bratt G, Hammarin AL, Grandien M, et al. BK virus as the cause of meningoencephalitis, retinitis and nephritis in a patient with AIDS. AIDS. 1999;13(9):1071–5.

    Article  PubMed  CAS  Google Scholar 

  26. Hirsch HH, Brennan DC, Drachenberg CB, et al. Polyomavirus-associated nephropathy in renal transplantation: interdisciplinary analyses and recommendations. Transplantation. 2005; 79(10): 1277–86.

    Article  PubMed  Google Scholar 

  27. Dharnidharka VR, Cherikh WS, Abbott KC. An OPTN analysis of national registry data on treatment of BK virus allograft nephropathy in the United States. Transplantation. 2009;87(7):1019–26.

    Article  PubMed  Google Scholar 

  28. Schold JD, Rehman S, Kayler LK, et al. Treatment for BK virus: incidence, risk factors and outcomes for kidney transplant recipients in the United States. Transpl Int. 2009;22(6):626–34.

    Article  PubMed  Google Scholar 

  29. Randhawa P, Baksh F, Aoki N, Tschirhart D, Finkelstein S. JC virus infection in allograft kidneys: analysis by polymerase chain reaction and immunohistochemistry. Transplantation. 2001; 71(9):1300–3.

    Article  PubMed  CAS  Google Scholar 

  30. Drachenberg CB, Hirsch HH, Papadimitriou JC, et al. Polyomavirus BK versus JC replication and nephropathy in renal transplant recipients: a prospective evaluation. Transplantation. 2007;84(3):323–30.

    Article  PubMed  Google Scholar 

  31. Ramos E, Drachenberg CB, Papadimitriou JC, et al. Clinical course of polyoma virus nephropathy in 67 renal transplant patients. J Am Soc Nephrol. 2002;13(8):2145–51.

    Article  PubMed  Google Scholar 

  32. Gardner SD, MacKenzie EF, Smith C, Porter AA. Prospective study of the human polyomaviruses BK and JC and cytomegalovirus in renal transplant recipients. J Clin Pathol. 1984; 37(5):578–86.

    Article  PubMed  CAS  Google Scholar 

  33. Bohl DL, Brennan DC, Ryschkewitsch C, et al. BK virus antibody titers and intensity of infections after renal transplantation. J Clin Virol. 2008;43(2):184–9.

    Article  PubMed  CAS  Google Scholar 

  34. Traystman MD, Gupta PK, Shah KV, et al. Identification of viruses in the urine of renal transplant recipients by cytomorphology. Acta Cytol. 1980;24(6):501–10.

    PubMed  CAS  Google Scholar 

  35. Drachenberg CB, Beskow CO, Cangro CB, et al. Human polyoma virus in renal allograft biopsies: morphological findings and correlation with urine cytology. Hum Pathol. 1999;30(8):970–7.

    Article  PubMed  CAS  Google Scholar 

  36. Singh HK, Andreoni KA, Madden V, et al. Presence of urinary Haufen accurately predicts polyomavirus nephropathy. J Am Soc Nephrol. 2009;20(2):416–27.

    Article  PubMed  CAS  Google Scholar 

  37. Hirsch HH, Knowles W, Dickenmann M, et al. Prospective study of polyomavirus type BK replication and nephropathy in renal-transplant recipients. N Engl J Med. 2002; 347(7):488–96.

    Article  PubMed  Google Scholar 

  38. Randhawa PS, Demetris AJ. Nephropathy due to polyomavirus type BK. N Engl J Med. 2000;342(18):1361–3.

    Article  PubMed  CAS  Google Scholar 

  39. Schmid H, Nitschko H, Gerth J, et al. Polyomavirus DNA and RNA detection in renal allograft biopsies: results from a European multicenter study. Transplantation. 2005;80(5):600–4.

    Article  PubMed  CAS  Google Scholar 

  40. Drachenberg CB, Papadimitriou JC. Polyomavirus-associated nephropathy: update in diagnosis. Transpl Infect Dis. 2006; 8(2):68–75.

    Article  PubMed  CAS  Google Scholar 

  41. Arthur RR, Shah KV. Occurrence and significance of papovaviruses BK and JC in the urine. Prog Med Virol. 1989;36:42–61.

    PubMed  CAS  Google Scholar 

  42. Howell DN, Smith SR, Butterly DW, et al. Diagnosis and management of BK polyomavirus interstitial nephritis in renal transplant recipients. Transplantation. 1999;68(9):1279–88.

    Article  PubMed  CAS  Google Scholar 

  43. Wiseman AC. Polyomavirus nephropathy: a current perspective and clinical considerations. Am J Kidney Dis. 2009; 54(1):131–42.

    Article  PubMed  Google Scholar 

  44. Drachenberg CB, Papadimitriou JC, Hirsch HH, et al. Histological patterns of polyomavirus nephropathy: correlation with graft outcome and viral load. Am J Transplant. 2004;4(12):2082–92.

    Article  PubMed  Google Scholar 

  45. Buehrig CK, Lager DJ, Stegall MD, et al. Influence of surveillance renal allograft biopsy on diagnosis and prognosis of polyomavirus-associated nephropathy. Kidney Int. 2003;64(2):665–73.

    Article  PubMed  Google Scholar 

  46. Brennan DC, Agha I, Bohl DL, et al. Incidence of BK with tacrolimus versus cyclosporine and impact of preemptive immunosuppression reduction. Am J Transplant. 2005;5(3):582–94.

    Article  PubMed  CAS  Google Scholar 

  47. Randhawa P, Brennan DC. BK virus infection in transplant recipients: an overview and update. Am J Transplant. 2006; 6(9):2000–5.

    Article  PubMed  CAS  Google Scholar 

  48. Hardinger KL, Koch MJ, Bohl DJ, Storch GA, Brennan DC. BK-virus and the impact of pre-emptive immunosuppression reduction: 5-year results. Am J Transplant. 2010;10(2):407–15.

    Article  PubMed  CAS  Google Scholar 

  49. Josephson MA, Williams JW, Chandraker A, Randhawa PS. Polyomavirus-associated nephropathy: update on antiviral strategies. Transpl Infect Dis. 2006;8(2):95–101.

    Article  PubMed  CAS  Google Scholar 

  50. Gabardi S, Waikar SS, Martin S, et al. Evaluation of fluoroquinolones for the prevention of BK viremia after renal transplantation. Clin J Am Soc Nephrol. 2010;5(7):1298–304.

    Article  PubMed  CAS  Google Scholar 

  51. Sener A, House AA, Jevnikar AM, et al. Intravenous immunoglobulin as a treatment for BK virus associated nephropathy: one-year follow-up of renal allograft recipients. Transplantation. 2006;81(1):117–20.

    Article  PubMed  CAS  Google Scholar 

  52. Casadei DH, del C Rial M, Opelz G, et al. A randomized and prospective study comparing treatment with high-dose intravenous immunoglobulin with monoclonal antibodies for rescue of kidney grafts with steroid-resistant rejection. Transplantation. 2001;71(1):53–8.

    Article  PubMed  CAS  Google Scholar 

  53. Josephson MA, Gillen D, Javaid B, et al. Treatment of renal allograft polyoma BK virus infection with leflunomide. Transplantation. 2006;81(5):704–10.

    Article  PubMed  CAS  Google Scholar 

  54. Vats A, Shapiro R, Singh Randhawa P, et al. Quantitative viral load monitoring and cidofovir therapy for the management of BK virus-associated nephropathy in children and adults. Transplantation. 2003;75(1):105–12.

    Article  PubMed  CAS  Google Scholar 

  55. Vandercam B, Moreau M, Goffin E, et al. Cidofovir-induced end-stage renal failure. Clin Infect Dis. 1999;29(4):948–9.

    Article  PubMed  CAS  Google Scholar 

  56. Muranyi W, Bahr U, Zeier M, van der Woude FJ. Hantavirus infection. J Am Soc Nephrol. 2005;16(12):3669–79.

    Article  PubMed  CAS  Google Scholar 

  57. Centers for Disease Control and Prevention CDC. Hantavirus pulmonary syndrome—five states, 2006. MMWR Morb Mortal Wkly Rep. 2006;55(22):627–9.

    Google Scholar 

  58. Glass GE, Watson AJ, LeDuc JW, Childs JE. Domestic cases of hemorrhagic fever with renal syndrome in the United States. Nephron. 1994;68(1):48–51.

    Article  PubMed  CAS  Google Scholar 

  59. Takeuchi T, Yamamoto T, Itoh M, et al. Clinical studies on hemorrhagic fever with renal syndrome found in Nagoya City University Medical School. Kidney Int Suppl. 1991;35:S84–7.

    PubMed  CAS  Google Scholar 

  60. Lee JS. Clinical features of hemorrhagic fever with renal syndrome in Korea. Kidney Int Suppl. 1991;35:S88–93.

    PubMed  CAS  Google Scholar 

  61. Miettinen MH, Mäkelä SM, Ala-Houhala IO, et al. Ten-year prognosis of Puumala hantavirus-induced acute interstitial nephritis. Kidney Int. 2006;69(11):2043–8.

    Article  PubMed  CAS  Google Scholar 

  62. Khaiboullina SF, Morzunov SP, St Jeor SC. Hantaviruses: molecular biology, evolution and pathogenesis. Curr Mol Med. 2005; 5(8):773–90.

    Article  PubMed  CAS  Google Scholar 

  63. Papadimitriou M. Hantavirus nephropathy. Kidney Int. 1995; 48(3):887–902.

    Article  PubMed  CAS  Google Scholar 

  64. Cosgriff TM, Lewis RM. Mechanisms of disease in hemorrhagic fever with renal syndrome. Kidney Int Suppl. 1991;35:S72–9.

    PubMed  CAS  Google Scholar 

  65. Temonen M, Mustonen J, Helin H, et al. Cytokines, adhesion molecules, and cellular infiltration in nephropathia epidemica kidneys: an immunohistochemical study. Clin Immunol Immunopathol. 1996;78(1):47–55.

    Article  PubMed  CAS  Google Scholar 

  66. Mustonen J, Partanen J, Kanerva M, et al. Genetic susceptibility to severe course of nephropathia epidemica caused by Puumala hantavirus. Kidney Int. 1996;49(1):217–21.

    Article  PubMed  CAS  Google Scholar 

  67. Mustonen J, Partanen J, Kanerva M, et al. Association of HLA B27 with benign clinical course of nephropathia epidemica caused by Puumala hantavirus. Scand J Immunol. 1998; 47(3):277–9.

    Article  PubMed  CAS  Google Scholar 

  68. Laine O, Mäkelä S, Mustonen J, et al. Enhanced thrombin formation and fibrinolysis during acute Puumala hantavirus infection. Thromb Res. 2010;126(2):154–8.

    Article  PubMed  CAS  Google Scholar 

  69. Puljiz I, Kuzman I, Markotic A, et al. Electrocardiographic changes in patients with haemorrhagic fever with renal syndrome. Scand J Infect Dis. 2005;37(8):594–8.

    Article  PubMed  Google Scholar 

  70. Mäkelä S, Kokkonen L, Ala-Houhala I, et al. More than half of the patients with acute Puumala hantavirus infection have abnormal cardiac findings. Scand J Infect Dis. 2009;41(1):57–62.

    Article  PubMed  CAS  Google Scholar 

  71. Paakkala A, Kallio T, Huhtala H, et al. Renal ultrasound findings and their clinical associations in nephropathia epidemica. Analysis of quantitative parameters. Acta Radiol. 2002;43(3):320–5.

    Article  PubMed  CAS  Google Scholar 

  72. Mustonen J, Helin H, Pietilä K, et al. Renal biopsy findings and clinicopathologic correlations in nephropathia epidemica. Clin Nephrol. 1994;41(3):121–6.

    PubMed  CAS  Google Scholar 

  73. Vapalahti O, Mustonen J, Lundkvist Å, et al. Hantavirus infections in Europe. Lancet Infect Dis. 2003;3(10):653–61.

    Article  PubMed  Google Scholar 

  74. Bharadwaj M, Nofchissey R, Goade D, Koster F, Hjelle B. Humoral immune responses in the hantavirus cardiopulmonary syndrome. J Infect Dis. 2000;182(1):43–8.

    Article  PubMed  CAS  Google Scholar 

  75. Saksida A, Duh D, Korva M, Avsic ZT. Dobrava virus RNA load in patients who have hemorrhagic fever with renal syndrome. J Infect Dis. 2008;197(5):681–5.

    Article  PubMed  CAS  Google Scholar 

  76. Poljak M, Avsic ZT. Immunohistochemical detection of Hantaan virus antigen in renal tissue from patient with hemorrhagic fever with renal syndrome. Nephron. 1994;67(2):252.

    Article  PubMed  CAS  Google Scholar 

  77. Green W, Feddersen R, Yousef O, et al. Tissue distribution of hantavirus antigen in naturally infected humans and deer mice. J Infect Dis. 1998;177(6):1696–700.

    Article  PubMed  CAS  Google Scholar 

  78. Nichol ST, Spiropoulou CF, Morzunov S, et al. Genetic identification of a hantavirus associated with an outbreak of acute respiratory illness. Science. 1993;262(5135):914–7.

    Article  PubMed  CAS  Google Scholar 

  79. Huggins JW, Hsiang CM, Cosgriff TM, et al. Prospective, double-blind, concurrent, placebo-controlled clinical trial of intravenous ribavirin therapy of hemorrhagic fever with renal syndrome. J Infect Dis. 1991;164(6):1119–27.

    Article  PubMed  CAS  Google Scholar 

  80. Miettinen MH, Mäkelä SM, Ala-Houhala IO, et al. The severity of acute Puumala hantavirus infection does not predict the long-term outcome of patients. Nephron Clin Pract. 2010; 116(2):c89–94.

    Article  PubMed  Google Scholar 

  81. Novo R, Gagnadoux MF, Le Guenno Y, et al. Chronic renal failure after Puumala virus infection. Pediatr Nephrol. 1999; 13(9):934–5.

    Article  PubMed  CAS  Google Scholar 

  82. Rarjacdhvttes BK. Serological studies of adenoviral hepatitis following pediatric liver transplantation. Transplant Proc. 1990; 22(4):1547.

    Google Scholar 

  83. Pacini DL, Collier AM, Henderson FW. Adenovirus infections and respiratory illnesses in children in group day care. J Infect Dis. 1987;156(6):920–7.

    Article  PubMed  CAS  Google Scholar 

  84. Ito M, Hirabayashi N, Uno Y, Nakayama A, Asai J. Necrotizing tubulointerstitial nephritis associated with adenovirus infection. Hum Pathol. 1991;22(12):1225–31.

    Article  PubMed  CAS  Google Scholar 

  85. Akiyama H, Kurosu T, Sakashita C, et al. Adenovirus is a key pathogen in hemorrhagic cystitis associated with bone marrow transplantation. Clin Infect Dis. 2001;32(9):1325–30.

    Article  PubMed  CAS  Google Scholar 

  86. Similä S, Jouppila R, Salmi A, Pohjonen R. Encephalomeningitis in children associated with an adenovirus type 7 epidemic. Acta Paediatr Scand. 1970;59(3):310–6.

    Article  PubMed  Google Scholar 

  87. de Mezerville MHN, Tellier R, Richardson S, et al. Adenoviral infections in pediatric transplant recipients. Pediatr Infect Dis J. 2006;25(9):815–8.

    Article  PubMed  Google Scholar 

  88. Echavarria M, Forman M, van Tol MJ, et al. Prediction of severe disseminated adenovirus infection by serum PCR. Lancet. 2001; 358(9279):384–5.

    Article  PubMed  CAS  Google Scholar 

  89. Lion T, Baumgartinger R, Watzinger F, et al. Molecular monitoring of adenovirus in peripheral blood after allogeneic bone marrow transplantation permits early diagnosis of disseminated disease. Blood. 2003;102(3):1114–20.

    Article  PubMed  CAS  Google Scholar 

  90. Leruez-Ville M, Minard V, Lacaille F, et al. Real-time blood plasma polymerase chain reaction for management of disseminated adenovirus infection. Clin Infect Dis. 2004;38(1):45–52.

    Article  PubMed  CAS  Google Scholar 

  91. Becroft DM. Histopathology of fatal adenovirus infection of the respiratory tract in young children. J Clin Pathol. 1967; 20(4):561–9.

    Article  PubMed  CAS  Google Scholar 

  92. Henry Pinkerton SC. Fatal adenovirus pneumonia in infants: correlation of histologic and electron microscopic observations. Am J Pathol. 1971;65(3):543.

    Google Scholar 

  93. Neofytos D, Ojha A, Mookerjee B, et al. Treatment of adenovirus disease in stem cell transplant recipients with cidofovir. Biol Blood Marrow Transplant. 2007;13(1):74–81.

    Article  PubMed  CAS  Google Scholar 

  94. Ljungman P, Ribaud P, Eyrich M, et al. Cidofovir for adenovirus infections after allogeneic hematopoietic stem cell transplantation: a survey by the Infectious Diseases Working Party of the European Group for Blood and Marrow Transplantation. Bone Marrow Transplant. 2003;31(6):481–6.

    Article  PubMed  CAS  Google Scholar 

  95. Vittecoq D, Dumitrescu L, Beaufils H, Deray G. Fanconi syndrome associated with cidofovir therapy. Antimicrob Agents Chemother. 1997;41(8):1846.

    PubMed  CAS  Google Scholar 

  96. Doan ML, Mallory GB, Kaplan SL, et al. Treatment of adenovirus pneumonia with cidofovir in pediatric lung transplant recipients. J Heart Lung Transplant. 2007;26(9):883–9.

    Article  PubMed  Google Scholar 

  97. Dagan R, Schwartz RH, Insel RA, Menegus MA. Severe diffuse adenovirus 7a pneumonia in a child with combined immunodeficiency: possible therapeutic effect of human immune serum globulin containing specific neutralizing antibody. Pediatr Infect Dis. 1984;3(3):246–51.

    Article  PubMed  CAS  Google Scholar 

  98. Munoz FM, Piedra PA, Demmler GJ. Disseminated adenovirus disease in immunocompromised and immunocompetent children. Clin Infect Dis. 1998;27(5):1194–200.

    Article  PubMed  CAS  Google Scholar 

  99. Dalldorf G, Sickles GM. An unidentified, filterable agent isolated from the feces of children with paralysis. Science. 1948; 108(2794):61–2.

    Article  PubMed  CAS  Google Scholar 

  100. Pasch A, Frey FJ. Coxsackie B viruses and the kidney—a neglected topic. Nephrol Dial Transplant. 2006;21(5):1184–7.

    Article  PubMed  Google Scholar 

  101. Burch G, Harb J. Coxsackie B4 viral infection of the human kidney. J Urol. 1974;112(6):714–22.

    PubMed  CAS  Google Scholar 

  102. Aronson M. Coxsackievirus B5 infections in acute oliguric renal failure. J Infect Dis. 1975;132(3):303–6.

    Article  PubMed  CAS  Google Scholar 

  103. Conaldi P, Biancone L, Bottelli A, et al. Distinct pathogenic effects of group B coxsackieviruses on human glomerular and tubular kidney cells. J Virol. 1997;71(12):9180.

    PubMed  CAS  Google Scholar 

  104. Page Y, Serrange C, Revillard J. Letter: Coxsackie B virus infections in kidney transplantation. Nouv Presse Med. 1976; 5(25):1587–8.

    PubMed  CAS  Google Scholar 

  105. Yoshida K, Suzuki J, Suzuki S, Kume K, Mutoh S, Kato K, Suzuki H. Experimental IgA nephropathy induced by coxsackie B 4 virus in mice. Am J Nephrol. 1997;17(1):81–8.

    Article  PubMed  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of Medicine, Division of Infectious Diseases, Mayo Clinic, Rochester, MN, USA

    Nathan W. Cummins M.D.

  2. Division of Infectious Diseases, Mayo Clinic, Rochester, MN, USA

    M. Rizwan Sohail M.D.

Authors
  1. Nathan W. Cummins M.D.
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. M. Rizwan Sohail M.D.
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to M. Rizwan Sohail M.D. .

Editor information

Editors and Affiliations

  1. Div. Nephrology & Hypertension, Mayo Clinic Dept. Internal Medicine, Rochester, Minnesota, USA

    Fernando C. Fervenza

  2. Renal Division, Brigham and Women's Hospital, Boston, Massachusetts, USA

    Julie Lin

  3. Mayo Clinic, Rochester, Minnesota, USA

    Sanjeev Sethi

  4. Renal Division, Brigham and Women's Hospital Harvard Medical School, Boston, Massachusetts, USA

    Ajay K. Singh

Rights and permissions

Reprints and permissions

Copyright information

© 2014 Springer Science+Business Media New York

About this chapter

Cite this chapter

Cummins, N.W., Sohail, M.R. (2014). Cytomegalovirus, BK, and Other Viral Infections of the Kidney. In: Fervenza, F., Lin, J., Sethi, S., Singh, A. (eds) Core Concepts in Parenchymal Kidney Disease. Springer, New York, NY. https://doi.org/10.1007/978-1-4614-8166-9_14

Download citation

  • DOI: https://doi.org/10.1007/978-1-4614-8166-9_14

  • Published:

  • Publisher Name: Springer, New York, NY

  • Print ISBN: 978-1-4614-8165-2

  • Online ISBN: 978-1-4614-8166-9

  • eBook Packages: MedicineMedicine (R0)

Publish with us

Policies and ethics

Search

Navigation